Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Acquisitions: 2015-2022

Historic Acquisitions for Fortress Biotech (FBIO) over the last 4 years, with Dec 2022 value amounting to -$20.0 million.

  • Fortress Biotech's Acquisitions rose 75.00% to -$5.0 million in Q1 2023 from the same period last year, while for Mar 2023 it was -$24.8 million, marking a year-over-year decrease of 25.36%. This contributed to the annual value of -$20.0 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Fortress Biotech reported Acquisitions of -$20.0 million as of FY2022, which was down 105,363.16% from $19,000 recorded in FY2017.
  • Fortress Biotech's Acquisitions' 5-year high stood at -$20.0 million during FY2022, with a 5-year trough of -$20.0 million in FY2022.
  • Over the past 1 years, Fortress Biotech's median Acquisitions value was -$20.0 million (recorded in 2022), while the average stood at -$20.0 million.